Recruiting NCT01577251
The Radiation Oncology Registry and Biosample Repository
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Neoplasia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Registry and Biosample Repository
Overview
The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.
Primary outcome measures
- Health Assessments [Time frame: 10 years]
Eligibility criteria
- Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
- Able to sign consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
United States · 4 centers
- Virtua Samson Cancer Center — Moorestown
- Virtua Health & Wellness Center — Voorhees Township
- Lancaster General Hospital — Lancaster
- University of Pennsylvania — Philadelphia
Identifiers
NCT: NCT01577251 · UPCC 11908